Amgen Inc. has acquired closely held human genetics firm deCODE genetics EHF for $415mm in cash. (Dec.)
DeCODE was formed in 1996 and brought in about $18mm through venture rounds before it went public in 2000, netting $185mm. After completing several PIPEs, the company filed for bankruptcy...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on In Vivo for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?